DUBLIN--(BUSINESS WIRE)--The "eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering.
The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%.
Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech companies are some of the major driving factors for the global eClinical solutions market.
Cloud-based (SaaS) segment is projected to record the highest CAGR
Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions. In 2020, the web-hosted (on-demand) segment commanded the largest share of the global eClinical solutions market. The increasing number of cloud-based clinical trial solutions in the market and the rising adoption of these solutions in clinical research studies (owing to advantages such as ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee) is fueling the growth of the cloud-based eClinical solutions market.
Phase III clinical trials is expected to register the highest growth during the forecast period
Based on the clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials. The phase III clinical trials segment accounted for the largest share of the eClinical solutions market in 2020. The large share of this segment is attributed to the high demand for eClinical solutions for phase III trials due to the involvement of thousands of patients in this phase.
CROs segment is estimated to record the highest CAGR in the forecast period
Based on end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the eClinical solutions market in 2020. However, the CROs segment is estimated to record the highest CAGR (15.5%) in the next five years. The increasing number of CROs in developed as well as developing countries, and the rising instances of clinical trial outsourcing to specialized clinical research organizations are responsible for the high growth rate of this segment.
North America to Witness Significant Growth from 2021 to 2026
In 2020, North America commanded the largest share of the eClinical solutions market. Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development is further stimulating the demand for eClinical solutions in this region.
Market Dynamics
Drivers
- Increasing Operational Costs and Regulatory Requirements Associated with Clinical Research Studies
- Growing Adoption of Novel Software Solutions in Clinical Research
- Increased Government Funding and Grants to Support Clinical Trials
- Need for Improved Data Standardization
- Increasing R&D Expenditure on Drug Development Pipeline by Pharma-Biotech Companies
- Growing Customer Base for Eclinical Solutions
Restraints
- High Implementation Costs Associated with Eclinical Solutions
- Dearth of Skilled Professionals to Operate Eclinical Solutions
- Limited Awareness of Advantages of Eclinical Solutions Among Researchers
Opportunities
- Increasing Clinical Research Activities in Emerging Asian Countries
- Greater Outsourcing of Clinical Trial Processes to Cros
- Rising Number of Clinical Trials in Emerging Countries
- Shift from Manual Data Interpretation to Real-Time Data Analysis During Clinical Studies
Challenges
- Limited Adoption of Eclinical Solutions in Developing Nations
- Concerns About Software Reliability
- Patient Privacy Issues
Companies Mentioned
- 4G Clinical
- Advarra
- Anju Software (Portfolio Company of Abry Partners)
- Aris Global
- Bioclinica, Inc. (Subsidiary of Cinven)
- Castor Edc
- Clinpace Clinical Research
- Dassault Systemes
- Datatrak International, Inc.
- Eclinical Solutions LLC
- Ert Clinical
- IBM Watson Health
- Maxisit Inc.
- Mednet
- Medrio Inc
- Openclinica
- Oracle Corporation
- Parexel International Corporation
- Quretec. Ltd
- Real Time Software Solutions
- Research Manager
- Saama Technologies
- Signant Health (Crf Health)
- Veeva Systems
- Yprime
For more information about this report visit https://www.researchandmarkets.com/r/hiugh7
